acerta pharma founder acerta pharma founder

CBI websites generally use certain cookies to enable better interactions with our sites and services. It started as a source code management solution for collaborating on software development inside a team, then developed into an integrated solution that covered the entire software development life cycle, and eventually to the entire DevOps life cycle. Tel: +56 (0)2 367 2000 As a comprehensive DevOps Platform, GitLabs application provides the capability to jointly plan, build, protect, and deploy software. Its features include application lifecycle management, source code management, roadmaps, incidents, container host security, time monitoring, and more. Iceland, Norway, Canada, and the Republic of Georgia all have their data centres. By simplifying financial services , it hopes to assist businesses in growing and democratising the digital economy. It provides liquidity for over 13,000 ETP listings across North America, Europe, and the Asia Pacific, making it one of the worlds largest ETP market makers. Dmitriy Zaporozhets of Ukraine and Sytse Sijbrandij of the Netherlands collaborated on the open-source software project. ACERTA PHARMA BV. Covey joined Kartos in April 2020 bringing over 25 years of industry experience in the hematology and inflammation fields. Acertas lead drug, Calquence (acalabrutinib) was approved by the FDA for mantle cell lymphoma in 2017 and CLL in 2020. Pharmaceutical and biotechnology companies with cancer therapy drug candidates. When it comes to the number of native unicorns, the Netherlands ranks fourth in Europe. This decision cleared the path for AstraZeneca to complete its acquisition. She served on Leadership Council for the Society of Toxicology PANWAT Chapter (2003-11, including President 2009-10). It may also be useful for the treatment of specific disease-modifying antirheumatic medications and the control of other cancers. From 1990 until his retirement from active military service in late 1994, General McPeak was Chief of Staff of the United States Air Force. Prior to joining Kartos, Dr. Slatter was VP for DMPK/Clinical Pharmacology at Acerta Pharma (a member of the AstraZeneca Group, 2014-18); Scientific Director (PKDM) and Medical Sciences Director (Clinical Pharmacology/Early Development) at Amgen (2006-14); Scientific Director (Preclinical Molecular Profiling) at Rosetta Inpharmatics/Merck (2003-06); Scientist II-IV (Drug Metabolism Research) and Associate Director (Life Cycle Management) at Pharmacia/Upjohn (1990-2003). [7] AcertaPharma is funded by 3 investors. Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces. Acerta Pharma has 8 executives. Mr. Rothbaum began his career at The Carson Group, a strategic consulting firm, where he managed its life sciences practice and boutique investment bank Evolution Capital. Prior to his role at Oxford, Mr. Sandler held various finance roles of increasing responsibility at Hyperion Therapeutics, Complete Genomics, Ipsen, Nektar Therapeutics, and Genentech. As a key Executive Leader he has been directly involved in the processes of growing up Acerta Pharma from 3 employees to 120 employees, increase company valuation from $2 million to $4 billion, acquire 2 compounds from big Pharma, and raise +$500 million in capital from investor Communities. He currently serves as a director on the boards of 3T Biosciences and Kartos Therapeutics. KARTOS THERAPEUTICS is a clinical stage biopharmaceutical company with an investigational MDM2 inhibitor (navtemadlin). Calquence is the brand name for Acalabrutinib, the active ingredient in the drug. Mollie is a payments platform that combines industry-leading security and convenience of use to create an ultra-secure, robust, and simple-to-implement payment integration procedure for websites and apps. Another advantage for Dutch companies is the ready availability of a skilled and bilingual workforce, thanks to the Dutch educational system. MessageBird is a communication services unicorn startup based in the Netherlands. It has extended its Middle East offering by opening a new office in Dubai. Before joining Acerta, Dr. McGreivy was the CMO at Pharmacyclics, where he oversaw the clinical development of ibrutinib (IMBRUVICA) and its successful global filings. Adyen increased its payment offering in Africa and launched additional functions in Tokyo and Mumbai in 2019. Acerta Pharma Profile and History . Risk management, revenue optimization, customer insights, and more are all included. The government releases modifications and extensions to current standards regularly. Mr. Mei holds a BS in Biochemistry and Molecular Biology from The University of California, Santa Cruz. He previously served as the Chief Financial Officer of Paulus Holdings Ltd. d/b/a LetsGetChecked. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. AstraZeneca purchased a 55 per cent stake in the company in December 2015. He also served as Corporate Controller and Director of Finance and Accounting for Personify, Inc., an e-commerce software company, and Controller of General Magic, Inc. Mr. Maynard has held various positions at Siliconix, Inc., including Senior Finance Manager. Elastic is an open-source search and analytics platform that runs in the cloud. Elastic filed for an initial public offering in June 2018, with an estimated valuation of 1.5 to 3 billion dollars. IOVANCE logo is a trademark owned, See Our Research Partners & Collaborators. The Enterprise Europe Network assists Dutch enterprises in growing worldwide, as well as encouraging and promoting new businesses through the Startup Delta programme, which aims to integrate the Dutch startup ecosystem into a single hub. It allows software developers to programmatically access their bank accounts and create apps, which bunq facilitates through its developer website and API marketplace. He holds a B.S. Flow Traders is globally recognised as a market leader and proprietary trading startup. It believes there should be no more paperwork, branch visits, or bureaucracy, just the flexibility to focus on what matters most- running your company. During her career in the industry, Flavia led the global development, approval and launch of several oncology drugs, including a first in class EGFR T790M inhibitor (osimertinib, AstraZeneca), a first in class BRAF inhibitor (vemurafenib, Roche), and served as the program leader for a HER2 Positive Metastatic Breast Cancer inhibitor (trastuzumab) and a EGFR tyrosine kinase inhibitor (erlotinib) at Genentech. Share this: Acerta Pharma's headquarters is located at Kloosterstraat 9, Oss. With continuous delivery monitoring tools, it provides real-time information. Adyen began growing globally in 2012, with operations in San Francisco, Paris, and London. As VP of Biology at Acerta Pharma, Mr. Prior to joining Kartos, he was the program lead for rovalpituzumab tesirine at Stemcentrx, prior to its acquisition by AbbVie. AstraZeneca acquired a majority stake interest in Acerta Pharma, which serves as AstraZeneca's haematology research and development centre of excellence. Hotmart is a one-stop shop where creators can launch their businesses and shoppers may find their next digital purchase. Through private blogs, websites, and other channels, affiliates can market and sell content to earn commissions. The unicorn states that it works 24 hours a day, 7 days a week to develop fintech solutions that make banking and money management as easy, transparent, and enjoyable as attainable. Director Discovery Haematology BioScience. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. MessageBird was valued at more than $3 billion in a financing round the same fall. In 2012, Mr. Rothbaum co-founded and was the Executive Chairman of Acerta Pharma, a private life sciences company he later sold to AstraZeneca. More recently, in 2019, he co-founded Telios Pharma after licensing a novel targeted therapy from Merck KGaA to treat selected blood cancers and ophthalmology diseases. In 2012, Mr. Rothbaum co-founded and was the Executive Chairman of Acerta Pharma, a private life sciences company he later sold to AstraZeneca. Previously, Dr. Dixon held executive management positions at West Pharmaceuticals, Osteotech and Centocor, as well as various positions at SmithKline and French (now GlaxoSmithKline) in marketing, regulatory affairs, project management and as a biochemist. As a member of the Joint Chiefs of Staff, General McPeak was a military advisor to the Secretary of Defense and the President of the United States. She currently serves on the board of directors of Alkermes Plc, Arvinas, Inc. and Black Diamond Therapeutics, Inc. Dr. Countouriotis received training at the University of California, Los Angeles and at the Fred Hutchinson Cancer Research Center in the Pediatric Hematology-Oncology Program. Click cancel to return to AstraZenecas site or continue to proceed. Learn more. She started her career as a Clinical Analyst at Doctor Evidence, a healthcare technology firm focused on developing a medical intelligence platform. It paid US$2.5 billion upfront and an additional US$1.5 billion after the medication passed further tests. This is no common neobank, as it proclaims itself the bank for The Free. It has grown across 30 European countries without the use of any venture capital funding and invites its customers to invest its funds. Valuation- $ 7.6 Billion Acerta Pharma B.v. (a Member Of The Astrazeneca Group) is a Pharmaceuticals company and has headquarters in North Brabant, Netherlands. Dr. Countouriotis is the President and Chief Executive Officer and a member of the Board of Directors of Turning Point Therapeutics. General McPeak previously served as a director of several public companies, including Tektronix, Inc., Trans World Airlines, Inc., and ECC International Corp., where he was for many years the Chairman of the Board. Content by MBS Value Partners| Design byPozati.com, Pablo Valenzuela, Ph.D Chief Executive Officer, Dr. Luis Burzio, PhD Head of Preclinical Research, Cristian Hernndez-Cuevas, Msc Chief Operating Officer, Bernardita Mndez Head of Regulatory Affairs and Intellectual Property, Patricio Cceres Head of Finance and Human Resources, Therapeutic Area Head at Elan Pharmaceuticals (2008-09), General Medicine Therapeutic Area Head at PDL Biopharma (2006-08), Medical Director at Johnson and Johnson/ALZA (2004-06), Senior Principal Scientist at Watson Pharmaceuticals (2000-04). This unicorn is a search startup that creates self-managed and SaaS products for use cases like site search, application search, logging, enterprise search, APM, security, metrics, and business analytics. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Mol founded Zaypay in 2007 to promote micropayments via SMS and 0900 numbers, and to handle these activities. AstraZeneca bought a controlling stake in Acerta Pharma in 2016, and the company was fully acquired by AstraZeneca in 2021. Acerta Pharma BV AstraZeneca Investigators Study Documents (Full-Text) Documents provided by Acerta Pharma BV: Study Protocol [PDF] February 12, 2020 Statistical Analysis Plan [PDF] February 3, 2020 More Information Go to Additional Information: redacted SAP redacted CSR synopsis redacted study protocol Keywords provided by Acerta Pharma BV: Elastic is a search startup that specialises in self-managed and SaaS solutions for search, logging, security, observability, and analytics. We encourage you to read the privacy policy of every website you visit. Dedicated to the development of novel, targeted therapeutics that meaningfully improve the lives of patients with cancer. Additionally, Mr. Rothbaum has taken a leadership role in transforming Iovance, restructuring and reorganizing its Board of Directors, senior management and overall clinical operations and strategy. For the past four years, Great Place to Work has named it one of the top medium-sized technology startups to work for. Claim your profile to get in front of buyers, investors, and analysts. Upon completion of the agreement, AstraZeneca acquired 55% of the entire issued share capital of Acerta for an upfront payment of $2.5 billion and a further unconditional payment of $1.5 billion, to be paid either on receipt of the first regulatory approval for acalabrutinib for any indication in the US, or the end of 2018, depending on which is first. Its BTK inhibitor, ACP-196, also known as acalabrutinib, is currently in clinical development. Before joining Schering-Plough, Mr. Piacquad spent more than 20 years at Johnson & Johnson, where he held a series of leadership roles in finance and business development. Erin received her undergraduate degree from the University of Southern California (USC) and completed her PhD in Molecular and Cellular Biology at the City of Hope. In 2016, Mr. Rothbaum also co-founded Kartos Therapeutics following the in-license of an investigational MDM2 inhibitor from Amgen. As SVP of Client Solutions at Vaniam Group (2016-19), she led medical and scientific teams and consulted with pharmaceutical clients commercializing in hematology. He retired from Amgen in 2022 after spending over a decade as the head of business development. In February 2016, AstraZeneca acquired a majority share of Acerta Pharma via a USD $4 billion investment and is a committed partner to the development of these innovative drugs. It covered, among other things, compensation for persons working in the hotel, tourism, and events industries, along with support in paying staff salaries and the expansion of business credit programmes. Ahmed Hamdy, MD Medical Allard Kaptein, PhD Discovery Raquel Izumi, PhD Clinical Operations Tjeerd Barf, PhD Chemistry Francisco Salva Finance & Operations from New York University School of Medicine, and completed a Ph.D. in Molecular Neurobiology at Cornell University Medical College. Acerta Pharma is included in 2 Expert Collections, including Cancer. Bunq is often referred to be a disruptor or challenger bank. This link will take you to a site maintained by a third party who is solely responsible for its content. When you use Elastic Enterprise Search, Observability, and Security products, you can rely on this startup to get things done faster. Prior to joining Actin Biomed, Dr. Weiser was the Director of Research at Paramount BioCapital, Inc., a pharmaceutical development and healthcare investment firm. The Netherlands has catapulted itself to the top of the European startup leaderboards, and it is identified as one of the worlds most interconnected economies as well as the fourth-best European country for startup movement, thanks to a holy trinity of a globally competitive talent pool, an abundance of incubator programmes, and a booming tech sector. She leads the Healthcare Businesswomens Association (HBA) Ambassador program at Amgen and holds an advisory board role for the Los Angeles chapter of the Association for Women in Science (AWIS). Its headquarters are in the Dutch city of Amsterdam, the Netherlands. BOM and BioGeneration Ventures are the most recent investors. Mr. Maynard currently serves as Chief Financial Officer of Cara Therapeutics, Inc., a publicly-traded commercial-stage biopharmaceutical company. Zaartu 1482, uoa, Santiago, Chile It was one of the first digital banks in Holland to start lending for retail mortgages. Get the full list, To view Acerta Pharmas complete patent history, request access, Youre viewing 1 of 18 executive team members. Mollie began focusing more on financial traffic, SMS, and telephony services in 2007. Its financial services are available to inhabitants of 30 European nations as of 2019. WeChat, Facebook, Deliveroo, Uber, and Telegram are all compatible. More than 100,000 people have joined the Elasticsearch meetup community. Dr Hamdy has +20 years of clinical research experience in pharmaceutical drug development, seven of which were in academic medical research. GitLab Inc. announced on October 14, 2021, that it would begin trading on the NASDAQ Global Select Market under the symbol GTLB. Dr. Krejsa has led early- and late-phase nonclinical and clinical translation programs for diverse small molecule and protein therapeutics in oncology, autoimmune and allergy indications. Initially, the company only sold text messages to businesses. Dr. Dixon also established and served as the executive sponsor for the BMS Womens Affinity Network, focused on gender diversity and inclusion priorities. Dr. Weiser is the Founder and a Principal of Actin Biomed LLC, a healthcare investment firm focused on the discovery and development of novel treatments for unmet medical needs. The unicorn is a digital product content distribution platform. Learn more. Acerta Pharma is a Haematological Oncology R&D centre of AstraZeneca. But over the weekend, it said that some early data for its drug acalabrutinib was falsified. AcertaPharma has raised a total of $60M in funding over 1 round. The company wants to invest in its dedicated employees since they are the foundation of its success. Our country sites can be located in the AZ Network. You can work from anywhere with good internet as part of the GitLab team. Following that, the video service 24sessions and the analysis firm Hull were purchased. site you are consenting to these choices. Status: Private. It has millions of students, over 150,000 products registered on its platform, sales in over 180 countries, and a global staff of over 700 people. The company specializes in the field of covalent binding technology to create novel, highly selective therapies for cancer, thereby enabling medical professionals to improve outcomes and enhance the lives of patients. It has headquarters in Amsterdam, Washington, D.C., and San Francisco at the moment. Acerta Pharma, a privately-owned biotech company that combines two technology platforms in drug discovery and development: the Covalent Technology Platform and the Multiparametric Phosphoflow Cytometry Platform. Vice President Europe & Site Head Acerta Oss. With team members in over 65 countries, it is the worlds largest all-remote corporation. It is now developing its business globally, with offices in Spain, Colombia, Mxico, and the Netherlands, as well as plans to open offices in many more countries, giving more people the chance to earn a living doing what they enjoy. Funding Rounds- 7 Mr. Rothbaum graduated Phi Beta Kappa from Binghamton University in 1990 with a dual major in political science and psychology and received his MA in international economics from The George Washington University. Previously, Dr. Dukes was Vice President of Scientific and Technology Licensing at GlaxoSmithKline, and he held various positions at Glaxo Wellcome, including Head of Exploratory Development for Metabolic and Urogenital Diseases and Head of Ion Channel Drug Discovery Group. In 2012, Mr. Rothbaum co-founded and was the Executive Chairman of Acerta Pharma, a private life sciences company he later sold to AstraZeneca. MessageBirds global business, based in Amsterdam, reaches billions of devices, services over 25,000 customers, and operates across nine hubs. Acerta Pharma is a leader in the field of covalent binding technology and is applying this technology to create novel, highly selective therapies for cancer. About Acerta Pharma. Covey remained in a leadership position, developing effective teams and biomarker strategies for Astrazenecas drug candidates. Flavia is the retired Chief Executive Officer for Acerta Pharma, where she led the organization to the approval of Calquence for Mantle Cell Lymphoma; she also served as the Global Franchise Head, Hematology at AstraZeneca, with responsibility for the hematology portfolio in the Oncology Business Unit. Flow Traders promotes a strong team-oriented culture in which employees are recognised for their contributions to the organisation as a whole rather than just in their immediate area of responsibility. Flavia holds a PhD in Pharmaceutical Chemistry from the University of Modena (Italy), and completed her post-doctoral training at the NCI. The company received a European banking licence in April 2017, giving it the status of an acquiring bank. San Francisco, Washington, D.C., Hong Kong, London, and Amsterdam are among the companys locations. Flow Traders has cultivated a strong team-oriented culture, is constantly growing in foreign markets and is always on the lookout for new talent. For enterprises, it is a payment issuance solution. Earlier in her career, Dr. Countouriotis led development of products for Pfizer and Bristol-Myers Squibb, including Sutent, Mylotarg, Bosulif and Sprycel. It creates methods using publicly available data and order kinds that are non-controversial, simple, and transparent. [6] It may be used both in relapsed as well as in treatment-naive settings. of Environmental Health Sciences. Bunq Business was designed to be the model bank account for time management. Up to 40% of the firm was floated by Flow Traders. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Valuation- $ 1 Billion Dr. Verstovsek received his MD and PhD from the University of Zagreb, Croatia. With at least 6 new medicines to be launched between 2014 and 2020 and a broad pipeline of small molecules and biologics in development, we are committed to advance New Oncology as one of AstraZenecas six Growth Platforms focused on lung, ovarian, breast and blood cancers. Acerta Pharma CEO, Founder, Key Executive Team, Board of Directors & Employees He also served on the Board of Directors of Emisphere Technologies, Inc., a pharmaceutical and drug delivery company, and Ziopharm Oncology, Inc., a publicly traded biopharmaceutical company focused on immunotherapies in oncology. Acerta Pharma is a leader in the field of covalent binding technology and is applying this technology to create novel, highly selective therapies for cancer. He also serves on the Boards of KaNDy Therapeutics (previously as Chairman), NeRRe Therapeutics, ENYO, Kyn Therapeutics and ReViral. Acerta Pharma B.v. (a Member Of The Astrazeneca Group) has 170 employees. Most recently he served as Chief Scientific Officer and a member of the Board of Directors at Acerta Pharma BV until the majority acquisition by AstraZeneca in 2016. In 2021, the company was determined as a unicorn. Acerta Pharma is an AstraZeneca European R&D centre focused on the research and development of new revolutionary medications for the treatment of haematological malignancies. Bitfury conducts blockchain research and makes research reports, whitepapers, and educational materials available on its website. Acerta Pharma Location 121 Oyster Point Blvd Fl 4, South San Francisco, California, 94080, United States Description Read More Acerta is a leader in the field of covalent binding technology and is applying this technology to create novel selective therapies intended for the treatment of cancer and autoimmune diseases. Designation based on positive results from two Phase III trials. As a member of the Executive Committee at BMS, she was deeply involved with the strategy and activities that transformed BMS into a highly successful specialty biopharmaceutical company. Before this, he co-founded Acerta Pharma, a member of the AstraZeneca Group, and has previously served as the Chief Executive and Medical Officer. These were subsequently resold to the companys customers. Companies must be privately held and valued at more than USD 1 billion to be considered unicorns. Its a distributed data search and analytics engine that can handle structured, unstructured, and time-series data. Data centres are owned by this corporation in Iceland and the Republic of Georgia. He received his medical degree from Ohio State University and completed his internship and residency in internal medicine, and his fellowship in hematology/oncology at Georgetown University. Adyen Issuing, a virtual and physical card-issuing firm, was founded the same year to supplement merchant payments services. Key: RIA - Respiratory, Inflammation and Autoimmunity, CVMD - Cardiovascular and Metabolic Disease, ING - Infection, Neuroscience and Gastrointestinal. The firm created software that allows businesses and institutions to communicate with their customers. Mr. Myers joined Kartos in May 2018 from AstraZeneca, where he was Director, Oncology Business Unit Strategy with a focus on Hematology-oncology. Mr. Year Founded: 2012. Current and savings accounts, NFC-enabled prepaid cards for online and offline shopping, bill payments, and money transfers are among the services it delivers. Dont let your products get skipped. From 2007 to 2010, Dr. Dukes was the President and Chief Executive Officer, and a member of the board of directors, of Essentialis Therapeutics, a clinical stage biotechnology company focused on the development of breakthrough medicines for the treatment of rare metabolic diseases. Funding Rounds- 4 Acerta Pharma BV: ClinicalTrials.gov Identifier: NCT02475681 Other Study ID Numbers: ACE-CL-007 : First Posted: June 19, 2015 Key Record Dates: Results First Posted: January 10, 2023: Last Update Posted: March 29, 2023 Last Verified: March 2023 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Customer care software with cloud-based SMS, voice, and chat APIs are available. From 2010 to 2014, he worked on a variety of oncology projects within clinical operations at Loxo Oncology and Pharmacyclics. Prior to Calistoga, Dr. Ulrich was Senior Scientific Director with Merck Research Laboratories/Rosetta Inpharmatics, Director of Regulatory Toxicology, Safety Pharmacology, Genetic Toxicology, Cellular and Molecular Toxicology, Microscopy and Microanalysis at Abbott Laboratories, and a Senior Scientist with The Upjohn Company and Pharmacia & Upjohn Inc. Dr. Ulrich holds several patents and has authored more than 125 publications. His role as a Leader in the Clinical Development field is a result of the multiple responsibilities and duties he has undertaken in the Pharmaceutical industry: Andes Biotechnologies | Back . Her team is responsible for identifying external opportunities and conducting technical diligence for all licensing, collaboration and acquisition deals across oncology therapeutics. Elastic purchased Endgame, an endpoint security company, in 2019. Our Translational Medicine (TM) team are actively implementing MRD endpoints in our clinical trials to understand what treatments can drive to MRD undetectable levels. It provides end-to-end infrastructure for payment networks like Visa and Mastercard. Ali Niknam, a Dutch-Canadian entrepreneur who formerly created web hosting service TransIP and The Datacenter Group, founded the unicorn in 2012. All rights reserved. Bitfury is developing solutions for the future using the most important millennium technology. In February 2016, AstraZeneca acquired a majority share of Acerta Pharma via a USD $4 billion investment and is a committed partner to the development of these innovative drugs. It focuses on the development of small molecule BTK inhibitors for cancer treatment. Bunq account holders are covered by the European Central Bank s Deposit Guarantee Scheme due to its banking licence. It oversees the solution for automatic response. Several local businesses are assisting emerging enterprises, including those that helped during the pandemic, by providing free or subsidised access to tools and services for communicating, sharing information, managing projects, and more. Furthermore, it has a private gym where its health instructors help its customers with customised sports programmes. . McPeak has extensive leadership experience in the military and as a member of public and private company boards of directors. Prior to this, Dr. McGreivy was CMO at Acerta Pharma where he built and managed Clinical, Drug Safety teams alongside leading late-stage development and registration strategy for acalabrutinib (CALQUENCE), culminating in the sale of Acerta to AstraZeneca for up to $7B. Prior to LetsGetChecked, he was the Chief Financial Officer of Blade Therapeutics, Inc., a privately held biotechnology company. Prior to joining Merck, Dr. Dukes was Vice President of External Research and Development at Amgen. In 2016, Mr. Rothbaum also co-founded Kartos Therapeutics following the in-license of an investigational MDM2 inhibitor from Amgen. This website uses cookies to improve the site and user experience. All GitLab repositories can be up to ten gigabytes in size. Professor of medicine & Head of the Krukenberg Cancer Center , University Hospital Halle (Saale). The technology platform acts as a payment gateway and a payment service provider, at the same time providing risk management and local acquiring. Expanding further into B-cell cancers, acalabrutinib is estimated to reach potential peak-year sales in excess of $5 billion globally. AstraZeneca acquired a majority stake interest in Acerta Pharma, which serves as AstraZeneca's haematology research and development centre of excellence. GitLab Inc. now employs people in 65 countries and territories.